| Castle Rock Rural Health Clinic | |
|
1400 Uinta Dr Green River WY 82935-5060 | |
| (307) 872-4500 | |
| (307) 872-4595 |
| Full Name | Castle Rock Rural Health Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 1400 Uinta Dr, Green River, Wyoming |
| Authorized Official Name and Position | Susan Bybee (CHIEF FINANCIAL OFFICER) |
| Authorized Official Contact | 3078724530 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Castle Rock Rural Health Clinic 1400 Uinta Dr Green River WY 82935-5060 Ph: (307) 872-4500 | Castle Rock Rural Health Clinic 1400 Uinta Dr Green River WY 82935-5060 Ph: (307) 872-4500 |
| NPI Number | 1952457996 |
|---|---|
| Provider Enumeration Date | 01/25/2007 |
| Last Update Date | 04/09/2008 |
| Medicare PECOS PAC ID | 2466340138 |
|---|---|
| Medicare Enrollment ID | O20080403000253 |
News Archive
For the first time, there will be a vaccine which protects against four strains of the flu virus. Until now, flu vaccines have only protected against three forms of the virus.
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
The transplantation unit at Jackson Memorial Hospital and the University of Miami, FL, USA has entered into a research project with the Allenex group company AbSorber. The project is a pilot study evaluating the endothelial cell cross match XM-ONE in their Living Donor program.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
La Jolla, CA-In order to preserve our DNA, cells have developed an intricate system for monitoring and repairing DNA damage. Yet precisely how the initial damage signal is converted into a repair response remains unclear. Researchers at the Salk Institute for Biological Studies have now solved a crucial piece of the complex puzzle.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952457996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (Wyoming) | Primary |
News Archive
For the first time, there will be a vaccine which protects against four strains of the flu virus. Until now, flu vaccines have only protected against three forms of the virus.
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
The transplantation unit at Jackson Memorial Hospital and the University of Miami, FL, USA has entered into a research project with the Allenex group company AbSorber. The project is a pilot study evaluating the endothelial cell cross match XM-ONE in their Living Donor program.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
La Jolla, CA-In order to preserve our DNA, cells have developed an intricate system for monitoring and repairing DNA damage. Yet precisely how the initial damage signal is converted into a repair response remains unclear. Researchers at the Salk Institute for Biological Studies have now solved a crucial piece of the complex puzzle.
› Verified 7 days ago
Arnold Family Chiropractic Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 705 Uinta Dr, Green River, WY 82935 Phone: 307-875-1926 Fax: 307-875-5223 | |
Best Care Family Practice Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 520 Wilkes Dr Ste 13, Green River, WY 82935 Phone: 307-212-6242 Fax: 307-448-2246 | |
Castle Rock Hospital District Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1400 Uinta Dr, Green River, WY 82935 Phone: 307-872-4500 Fax: 307-872-4595 | |
Sweetwater County Child Developmental Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1715 Hitching Post, Green River, WY 82935 Phone: 307-875-0268 Fax: 307-875-3805 | |
Imed Heart - Green River Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1400 Uinta Dr, Green River, WY 82935 Phone: 801-507-3500 |